Description     Claims  

WO2011073845A   [0005] 
WO2010028174A   [0006] 
WO9308171A   [0008] 
US6106864A   [0380] 
WO0035298A   [0380] 
WO9111172A   [0402] 
WO9402518A   [0402] 
WO9855148A   [0402] 

Dopamine receptors: from structure to function   [0002] 
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction   [0003] 
D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys   [0003] 
The role of dopamine in modulating the structure and function of striatal circuits   [0003] 
Novel porphyrin-quinazoline conjugates via the Diels-Alder reaction   [0007] 
Handbook of Pharmaceutical Salts: Properties, Selection, and Use   [0286] 
Chem. Commun.   [0293] 
J. Pharm. Sci.   [0293] 
Crystals and the Polarizing Microscope   [0294] 
Pro-drugs as Novel Delivery Systems   [0295] 
Bioreversible Carriers in Drug Design   [0295] 
Design of Prodrugs   [0296]  [0362] 
Prodrugs: Challenges and Reward   [0296] 
Absolute Configuration Determination of Chiral Molecules in the Solution State Using Vibrational Circular Dichroism   [0301] 
Atroposelective Synthesis of Axially Chiral Biaryl Compounds   [0301] 
JPET   [0318] 
Protective Groups in Organic Synthesis   [0335] 
J. Organomet. Chem.   [0337] 
Chem. Rev.   [0337] 
J. Am. Chem. Soc.   [0337] 
Organic Reactions   [0337] 
Tetrahedron   [0337] 
Stereochemistry of Organic Compounds   [0353]  [0360] 
Remington's Pharmaceutical Sciences   [0364] 
Expert Opinion in Therapeutic Patents   [0365] 
Pharmaceutical Dosage Forms: Tablets   [0373] 
Pharmaceutical Technology On-line   [0380] 
J. Pharm. Sci.   [0386] 
Tetrahedron: Asymmetry   [0423] 
Tetrahedron   [0481] 
Bull. Chem. Soc. Jpn.   [0488] 
Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists   [0489]